Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Ascendis Pharma Ads (ASND)

$137.00 3.40 (2.54%)

16:00 EST ASND Stock Quote Delayed 15 Minutes

Volume:

Previous Close $137.00

Market Cap 5.72B

PE Ratio -

EPS -

Volume (Avg. Vol.) 200,400

Day's Range 131.18 - 138.56

52-Week Range 66.11 - 142.94

Dividend & Yield N/A (N/A)

ASND Stock Predictions, Articles, and Ascendis Pharma Ads News

From the Web

Best & Worst Performing Mid Cap Stocks for January 22, 2020

From StockNews.com Jan 22, 2020

LX – LX leads the way today as the best performing mid cap stock, closing up 13.75%.

98 Biotechnology Stocks Moving In Wednesday's Session

From Benzinga Jan 22, 2020

Gainers • Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 131.7% to $3.36 during Wednesday's regular session. • Genprex, Inc. (NASDAQ:GNPX) shares moved upwards by...

The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics

From Benzinga Jan 16, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ...

Stocks That Hit 52-Week Highs On Wednesday

From Benzinga Jan 15, 2020

On Wednesday, 277 companies set new 52-week highs. Noteworthy Points: NextEra Energy (NYSE: NEE) was the largest company by market cap to set a new 52-week high this...

The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger

From Benzinga Jan 3, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) Agile Therapeutics Inc (...

The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe

From Benzinga Jan 2, 2020

The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 31.)...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

A

Strong Buy